ATE155689T1 - Aktivätsmessungen des amylin - Google Patents

Aktivätsmessungen des amylin

Info

Publication number
ATE155689T1
ATE155689T1 AT92904180T AT92904180T ATE155689T1 AT E155689 T1 ATE155689 T1 AT E155689T1 AT 92904180 T AT92904180 T AT 92904180T AT 92904180 T AT92904180 T AT 92904180T AT E155689 T1 ATE155689 T1 AT E155689T1
Authority
AT
Austria
Prior art keywords
amylin
rise
lactate
simulate
determining
Prior art date
Application number
AT92904180T
Other languages
English (en)
Inventor
Andrew Young
Garth James Smith Cooper
Timothy J Rink
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/640,478 external-priority patent/US5234906A/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE155689T1 publication Critical patent/ATE155689T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92904180T 1991-01-10 1992-01-10 Aktivätsmessungen des amylin ATE155689T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/640,478 US5234906A (en) 1991-01-10 1991-01-10 Hyperglycemic compositions
US66652791A 1991-03-08 1991-03-08

Publications (1)

Publication Number Publication Date
ATE155689T1 true ATE155689T1 (de) 1997-08-15

Family

ID=27093565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904180T ATE155689T1 (de) 1991-01-10 1992-01-10 Aktivätsmessungen des amylin

Country Status (10)

Country Link
US (1) US6048514A (de)
EP (1) EP0525149B1 (de)
JP (1) JP2818296B2 (de)
AT (1) ATE155689T1 (de)
CA (1) CA2077265A1 (de)
DE (1) DE69221040T2 (de)
DK (1) DK0525149T3 (de)
ES (1) ES2107528T3 (de)
GR (1) GR3024812T3 (de)
WO (1) WO1992011863A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
JP2820797B2 (ja) * 1992-05-15 1998-11-05 アミリン・ファーマシューティカルズ，インコーポレイテッド アミリンの抗体アッセイ法
AU6249594A (en) * 1993-02-12 1994-08-29 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
US20040038861A1 (en) * 2001-11-26 2004-02-26 Cooper Garth J. S. Methods and compositions for normalizing lipid levels in mammalian tissues
US20040142393A1 (en) * 2002-08-01 2004-07-22 Cooper Garth James Smith Methods of use of compounds with preptin function
US7339347B2 (en) * 2003-08-11 2008-03-04 Reserve Power Cell, Llc Apparatus and method for reliably supplying electrical energy to an electrical system
EP1719447A1 (de) * 2005-05-07 2006-11-08 F. Hoffmann-La Roche AG Verfahren und Vorrichtung zur Bestimmung der Glucose-Konzentration in Gewebflüssigkeit
KR101721787B1 (ko) * 2007-08-24 2017-03-30 바스프 에스이 벤조트리아졸 및 메로시아닌을 포함하는 혼합물
JP6358942B2 (ja) * 2014-12-05 2018-07-18 沢井製薬株式会社 エンドトキシンの測定用試薬及びエンドトキシンの測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
US5280014A (en) * 1988-01-11 1994-01-18 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists

Also Published As

Publication number Publication date
EP0525149B1 (de) 1997-07-23
JP2818296B2 (ja) 1998-10-30
WO1992011863A1 (en) 1992-07-23
CA2077265A1 (en) 1992-07-11
ES2107528T3 (es) 1997-12-01
EP0525149A1 (de) 1993-02-03
DK0525149T3 (da) 1997-12-01
US6048514A (en) 2000-04-11
GR3024812T3 (en) 1998-01-30
JPH05505625A (ja) 1993-08-19
DE69221040T2 (de) 1997-11-13
EP0525149A4 (en) 1993-08-25
DE69221040D1 (de) 1997-09-04

Similar Documents

Publication Publication Date Title
TW369599B (en) A reagent strip and a method for measuring glucose concentration in a sample of whole blood
DE69910003D1 (de) Überwachung physiologischer analyte
NO844143L (no) Polymere katalysator transducere og deres bruk i proevesett for analytiske metoder
RU2002113055A (ru) Тестирующая полоска с реагентом для определения содержания анализируемого вещества
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
AU2303195A (en) Process and device for the analysis of glucose in a biological sample
SE8804074D0 (sv) Sensorenhet och dess anvaendning i biosensorsystem
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
DE60018537D1 (de) Teststreifen zur Bestimmung eines Analyts in eine flüssige Probe
ATA114789A (de) Verfahren und vorrichtung zur feststellung biologischer aktivitaeten in einer probe
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
KR880004314A (ko) 생리 활성물질 측정법
EP0353985A3 (de) Nukleinsäureprobe zur Detektion von Neisseria gonorrhoea
DE69221040D1 (de) Aktivätsmessungen des amylin
DE69812229D1 (de) Diagnostische Teststreifen mit integriertem Referenzabschnitt
NO950426D0 (no) Analyse for bestemmelse av protein i en biologisk pröve
NO953770L (no) Analysemetode
KR900700883A (ko) 식육의 질을 평가하기 위한 스카톨의 검출방법
GB8723796D0 (en) Rheometrics & viscoelastic measurement
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
ES8504218A1 (es) Sistema de diagnostico de parasitosis y alergias
ATE184323T1 (de) Nukleinsäurenachweis
Hansen-Smith et al. Alternative histochemical markers for skeletal muscle capillaries: a statistical comparison among three muscles
NO920624L (no) Reagens for paavisning av fibrinolytisk aktivitet

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee